UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
Search results for:
DOXOrubicin
DOXOrubicin
- Hazardous Drugs System Hazardous Drugs List Link
- Look Alike/Sound Alike System LASA Drugs List Link
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DOXOrubicin | POWDER FOR INJECTION, INTRAVENOUS | 50 mg | ||||||||||||||
| DOXOrubicin | SOLUTION, INJECTABLE | 25 mg/mL | ||||||||||||||
| DOXOrubicin | SOLUTION, INTRAVENOUS | 2 mg/mL (100 mL) | ||||||||||||||
| DOXOrubicin | SOLUTION, INTRAVENOUS | 2 mg/mL (10 mL) | ||||||||||||||
| DOXOrubicin | SOLUTION, INTRAVENOUS | 2 mg/mL (5 mL) | ||||||||||||||
| DOXOrubicin | SOLUTION, INTRAVENOUS | 2 mg/mL (25 mL) |
Last updated: Sep. 22, 2023
- Black Box Warning: Cardiac, hepatic, myelosuppression, extravasation risk
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions